ArticlePlastic and reconstructive surgery. Global open2026
Acellular Dermal Matrix-Associated Recurrent Capsular Contracture in a Breast Augmentation Patient.
Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Capsular contracture (CC) is a common complication following breast augmentation. Acellular dermal matrix (ADM) is increasingly used to reduce and treat CC in breast augmentation. However, rare cases of ADM-associated CC can occur. In this case report, we describe a 63-year-old breast augmentation patient who developed significant recurrent CC following subglandular augmentation, capsulectomies, and ADM-assisted revisions. Despite ADM coverage, the patient developed Baker grade 3 CC. Histologic and immunohistochemical analyses were performed on capsular tissue adjacent to visible ADM (study ADM) and on capsule without ADM contact (study capsule), and the results were compared with benign controls. Study ADM demonstrated histologic evidence of ADM resorption and increased fibrotic density. Study capsule exhibited the greatest capsule thickness. Immunohistochemistry revealed significantly elevated macrophages (CD68+,
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.